CULLINAN THERAPEUTICS INC (CGEM) Stock Analyst Ratings
USA - NASDAQ:CGEM - US2300311063 - Common Stock
8.655 USD
+0.38 (+4.66%)
ChartMill assigns a Buy % Consensus number of 87% to CGEM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 26.86. This target is 210.34% above the current price.
CGEM was analyzed by 17 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about CGEM.
In the previous month the buy percentage consensus was at a similar level.
CGEM was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-10 | BTIG | Reiterate | Buy -> Buy |
| 2025-08-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-06-11 | Stifel | Reiterate | Buy |
| 2025-05-12 | UBS | Maintains | Buy -> Buy |
| 2025-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-24 | UBS | Initiate | Buy |
| 2024-10-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-18 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-01 | Stifel | Initiate | Buy |
| 2024-04-17 | JonesTrading | Maintains | Buy -> Buy |
| 2024-04-17 | BTIG | Maintains | Buy -> Buy |
| 2024-04-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-15 | William Blair | Initiate | Outperform |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-15 | Wedbush | Initiate | Outperform |
| 2023-10-06 | JonesTrading | Initiate | Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-07-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-15 | TD Cowen | Initiate | Outperform |
CULLINAN THERAPEUTICS INC / CGEM FAQ
Can you provide the average price target for CULLINAN THERAPEUTICS INC stock?
17 analysts have analysed CGEM and the average price target is 26.86 USD. This implies a price increase of 210.34% is expected in the next year compared to the current price of 8.655.
How do analysts rate CULLINAN THERAPEUTICS INC (CGEM)?
The consensus rating for CULLINAN THERAPEUTICS INC (CGEM) is 87.0588 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for CGEM stock?
The number of analysts covering CULLINAN THERAPEUTICS INC (CGEM) is 17.